We are live on ! Find out more

Small Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BCRX icon
1
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.45 2.1%
ETON icon
2
Eton Pharmaceutcials
ETON
$1.84B
$1.84B $63.88 0.08%
TRLV icon
3
Trulieve Cannabis
TRLV
$1.76B
$1.76B $10.33 5.23%
ANIP icon
4
ANI Pharmaceuticals
ANIP
$1.62B
$1.62B $70.89 0.77%
ALVO icon
5
Alvotech
ALVO
$1.5B
$1.5B $4.41 5.25%
PAHC icon
6
Phibro Animal Health
PAHC
$1.46B
$1.46B $35.02 2.64%
PCRX icon
7
Pacira BioSciences
PCRX
$1.46B
$1.46B $36.48 0.05%
AMPH icon
8
Amphastar Pharmaceuticals
AMPH
$1.24B
$1.24B $29.17 0.68%
CRON icon
9
Cronos Group
CRON
$1.2B
$1.2B $3.27 3.25%
HROW icon
10
Harrow
HROW
$1.09B
$1.09B $29.09 3.42%
IRWD icon
11
Ironwood Pharmaceuticals
IRWD
$803M
$803M $4.85 0.41%
COLL icon
12
Collegium Pharmaceutical
COLL
$787M
$787M $25.43 0.43%
EVO icon
13
Evotec
EVO
$554M
$554M $1.56 1.27%
TKNO icon
14
Alpha Teknova
TKNO
$516M
$516M $7.77 5.36%
AQST icon
15
Aquestive Therapeutics
AQST
$473M
$473M $3.76 3.84%
KMDA icon
16
Kamada
KMDA
$468M
$468M $8.11 0.25%
EOLS icon
17
Evolus
EOLS
$461M
$461M $6.63 4.74%
TLRY icon
18
Tilray
TLRY
$346M
$346M $2.34 3.7%
ACB icon
19
Aurora Cannabis
ACB
$303M
$303M $4.61 6.68%
EBS icon
20
Emergent Biosolutions
EBS
$298M
$298M $5.81 0.35%

Small Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 20 small cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $250M and $2B — worth a combined $20.1B.

The largest by market cap are BioCryst Pharmaceuticals (BCRX) at $1.92B, Eton Pharmaceutcials (ETON) at $1.84B and Trulieve Cannabis (TRLV) at $1.76B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.